Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability
Jordi Bonaventura(National Institute on Drug Abuse), Sherry Lam(National Institute on Drug Abuse), Meghan L. Carlton(National Institute on Drug Abuse), Matthew A. Boehm(National Institute on Drug Abuse), Juan L. Gomez(National Institute on Drug Abuse), Óscar Solís(National Institute on Drug Abuse), Marta Sánchez‐Soto(National Institute of Neurological Disorders and Stroke), Patrick J. Morris(National Center for Advancing Translational Sciences), Ida Fredriksson(National Institute on Drug Abuse), Craig J. Thomas(National Center for Advancing Translational Sciences), David R. Sibley(National Institute of Neurological Disorders and Stroke), Yavin Shaham(National Institute on Drug Abuse), Carlos A. Zarate(National Institute of Mental Health), Michael Michaelides(National Institute on Drug Abuse)
Cited by 259Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis